IDH1 and glioblastoma: In support of this, reduction in TET2 enzyme levels by promoter methylation has recently been reported in low grade diffuse gliomas lacking IDH1/2 mutations [46], and loss of the TET2 locus (4q24) has been reported in approximately 2% of glioblastomas [35].